Non-Viral Vectors Delivering Stably Integrating DNA for In Vivo CAR T Therapy
Time: 1:00 pm
day: Day Two
Details:
- Understanding the complexities of cell-targeted lipid nanoparticles, co-loaded with DNA and RNA for in vivo cell engineering
- Exploring manufacturing scalability for drug substances and drug product
- Strategies for mitigating toxicities and for maximizing treatment effect
